The secure communication platform will allow for mobile and desktop messaging across the Medical Center’s network of four hospitals
Lexington, Mass. — January 12, 2015— Imprivata® (NYSE: IMPR) today announced that it expects its fourth quarter 2014 revenue to exceed the upper end of its previously announced guidance range of $26 to $27 million. During the quarter, the company continued to invest in sales and marketing, and in the development of new solutions that will leverage Imprivata’s authentication platform and drive long-term growth.
DWS es una compañía dedicada a brindar soluciones integrales en tecnología de la información, desde hace más de 18 años. DWS genera recursos estratégicos que lo convierten en un socio clave ayudandolo a minimizar costos y aumentar beneficios.
Clinical portal from Orion Health with single sign-on from Imprivata will provide clinicians with fast, secure 24/7 real-time access to health records
SHEFFIELD, UK, January 14, 2015 – HP Enterprise Services UK today announced that it has been selected by Sheffield Teaching Hospitals NHS Foundation Trust as prime contractor in a project to improve patient care by enabling an integrated view of patient information.
Imprivata Webinar on February 10 to Bring Together Leading Industry Experts to Help Hospitals and Providers Better Understand Regulatory and Technology Requirements for EPCS
Secure text messaging isn't only helping to expedite patient care and caregiver response at a South Carolina hospital, it's boosting staff efficiency and enabling treatment interaction by caregivers who live in remote areas with unreliable cell coverage.
Electronic Prescribing of Controlled Substances (EPCS) can help in achieving Meaningful Use (MU) requirements for e-prescribing. E-prescribing is a core measure of MU. Enabling EPCS increases organizations’ e-prescribing ratios by eliminating dual workflows and allows for a single, streamlined prescription workflow. MU e-prescribing requirements are going to become more stringent in the future so enabling EPCS today is a strategic step to future success. Imprivata Confirm ID™ is a fast, secure signing solution for enabling EPCS.
Electronic Prescribing of Controlled Substances (EPCS) can help curb DEA number theft and protect against fraudulent prescription practices. EPCS is more secure than paper prescriptions. With EPCS, prescriptions are automatically sent to patients’ pharmacies without patients ever seeing their doctors’ DEA number printed on their scripts. Imprivata Confirm ID™ is a fast, secure signing solution for enabling EPCS.
Electronic Prescribing of Controlled Substances (EPCS) can eliminate dual prescribing workflows and enhance patient satisfaction. Without EPCS, prescribers are tasked to complete two different prescribing processes creating an inefficient and confusing prescribing workflow for both the prescriber and patient. Patients are often prescribed a mix of paper and electronic prescriptions creating patient dissatisfaction. By enabling EPCS with Imprivata Confirm ID™ all prescribing is streamlined into a single, secure workflow.